Browse Articles

Examining the impact of consecutive losses on gambling: When do we decide to quit?

Kim et al. | Apr 28, 2026

Examining the impact of consecutive losses on gambling: When do we decide to quit?
Image credit: Kim, Cragun, and Kim

This article explored the question of when do people decide to stop gambling and further tries to extrapolate why people stop gambling at that point. Their study showed that people tend to quit gambling after 4 consecutive losses, significantly more than 1-3 consecutive losses or a win previous to quitting. They also found that participants commonly quit at a point value approximately 5 points greater than or less than their starting balance. The authors concluded that these results may be important in understanding how to cut down on excessive gambling or in creating policies that make it easier for people to disengage from gambling.

Read More...

Effects of plant-derived smoke water on germination and growth in stressed plants

Ge et al. | Apr 08, 2026

Effects of plant-derived smoke water on germination and growth in stressed plants

Here the authors investigated the potential of plant-derived smoke water to mitigate the negative impacts of abiotic stressors, such as heat, salinity, and water fluctuations, on the germination and growth of various agricultural crops. Their findings suggest that smoke water, specifically from buckwheat, pea, and radish, significantly improves plant resilience against drought and excessive water stress, offering a viable strategy to bolster food security in the face of climate change.

Read More...

VISTA inhibitor CA170 combined with KRAS vaccine enhances immune response in lung cancer

Giglio et al. | Mar 16, 2026

VISTA inhibitor CA170 combined with <i>KRAS</i> vaccine enhances immune response in lung cancer
Image credit: Robina Weermeijer

Here the authors investigated a combination therapy to target the Kirsten rat sarcoma viral oncogene homolog mutation in lung cancer, by analyzing publicly available data. Their findings indicate that the combination therapy of CA170 and Kvax enhances helper T cell function and improves cytotoxic T lymphocyte infiltration, while Kvax alone drives plasma and memory B cell proliferation.

Read More...